ORCID
- Salih, Vehid: 0000-0003-3776-2941
- Foey, Andrew: 0000-0003-0419-2268
Abstract
Chimeric antigen receptor T (CAR-T) cell therapy has shown great success in treating B cell malignancies however, there are many challenges which limit their therapeutic efficacy in solid tumours. Immunotherapy of head and neck squamous cell carcinoma (HN
DOI
10.3389/fdmed.2023.1116402
Publication Date
2023-03-13
Publication Title
Frontiers in Dental Medicine
Volume
4
Embargo Period
2023-04-18
Organisational Unit
Peninsula Dental School
Recommended Citation
Summers, S. E., Salih, V., & Foey, A. (2023) 'ErbB- and MUC1-targetted CAR-T cell immunotherapy of oral squamous cell carcinoma', Frontiers in Dental Medicine, 4. Available at: https://doi.org/10.3389/fdmed.2023.1116402
